Background: Mazabraud syndrome is a rare disorder, characterized by the presence of fibrous dysplasia (FD) with associated intramuscular myxomas. Data are scarce on the prevalence, clinical features, and natural history of this disorder and outcomes. In this multicenter study, we evaluated a series of patients from 6 European centers.
Methods: All centers affiliated with the European Musculo-Skeletal Oncology Society (EMSOS) were invited to include data on all patients with Mazabraud syndrome who were seen between 1980 and 2015. The study investigated the prevalence of Mazabraud syndrome, the type, severity, and localization of FD lesions in relation to myxomas, the histopathology of myxomas, and results of GNAS-mutation analysis, when available.
Results: Thirty-two patients (22 female) from 6 centers were included. The prevalence of Mazabraud syndrome was 2.2% in the combined cohort of 1,446 patients with FD, and the syndrome was diagnosed at a mean of 10.1 years after diagnosis of FD. The myxomas were predominantly localized in the upper leg. Excision was performed in 20 patients, recurrence occurred in 6 of these patients (30%) at a median of 8.5 years (range, 1.9 to 16.0 years), and revision surgery was necessary in 5 (25%). High cellularity of myxomas was associated with recurrence (p < 0.05). A GNAS mutation was identified in the myxoma tissue of 5 (83%) of 6 patients with GNAS-mutation analysis.
Conclusions: This study is the first, to our knowledge, to provide data on the prevalence of Mazabraud syndrome in a relatively large cohort. Although the outcomes of surgical resection were good, a quarter of the patients required revision surgery despite clear resection margins. High cellularity of myxomas was associated with recurrence. GNAS mutations were identified in 83% (5 of 6), emphasizing the shared origin of FD and myxomas. Our data show that patients with FD who have disproportionate complaints, irrespective of FD type, extent, or severity, should be investigated for the possible presence of myxomas.
Level Of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.18.00062 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incidental diagnosis of Mazabraud syndrome presenting as a lower extremity soft tissue mass: A case report and literature review.
Int J Surg Case Rep
December 2024
American British Cowdray Medical Center, 154 Carlos Graef Fernandez Av, Central Tower, medical office 515, Mexico City 05300, Mexico.
Introduction And Importance: Mazabraud's syndrome is a rare condition, describing the presence of fibrous bone dysplasia and intramuscular myxomas, with an incidence of 1:1,000,000. The aim of this article is to provide a review of the clinical presentation of Mazabraud's syndrome, including indications for surgical treatment, and follow-up strategies.
Case Presentation: A 46-year-old woman presented with a 3-month history of a painless mass in the right gluteal region, she referred a rapid increase in the mass's volume in the 3 weeks prior to consultation.
Myxoma: An Unusual Aggressive Orbital Lesion.
Ophthalmic Plast Reconstr Surg
January 2025
South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, Australia.
Myxoma is a rare tumor that can be challenging to diagnose, with imaging findings that can be nonspecific. We present a case of a 21-year-old man who presented with a subacute history of right visual deterioration and proptosis. Imaging showed a large right superomedial orbital mass of 43 × 31 × 24 mm, which enhanced heterogeneously and was eroding the adjacent orbital roof and medial wall.
View Article and Find Full Text PDFMazabraud's syndrome in female patients: Two case reports.
World J Orthop
June 2024
Department of Orthopedics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang Province, China.
Background: Mazabraud's syndrome (MS) is a rare and slowly progressive benign disease characterized by the concurrent presence of fibrous dysplasia of bone and intramuscular myxoma, and is thought to be associated with mutations of the gene. To date, only about 100 cases of MS have been reported in the literature, but its standard treatment strategy remains unclear.
Case Summary: We report two cases of MS in young women who underwent different treatments based on their symptoms and disease manifestations.
Fibrous dysplasia: A tale of two syndromes.
SA J Radiol
May 2024
Department of Radiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Article Synopsis
- - Fibrous dysplasia (FD) is a rare bone disorder that can occur in one (monostotic) or multiple (polyostotic) bones and can sometimes be linked to syndromes with additional symptoms.
- - Two syndromes related to FD are Mazabraud syndrome, which features polyostotic FD along with muscle tumors, and McCune-Albright syndrome, characterized by polyostotic FD, early puberty, and skin spots.
- - Diagnosis typically involves recognizing specific bone features in imaging, but MRI can sometimes confuse the condition with more serious issues; catching these disorders early is crucial for effective treatment and minimizing complications.
Mazabraud Syndrome: Clinical Review and Therapeutic Approach Regarding a Case Report.
Acta Med Port
April 2024
UNAERP Campus Guarujá. Guarujá. São Paulo. Portugal.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!